Emc Capital Management Athira Pharma, Inc. Transaction History

Emc Capital Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$9.17 - $16.39 $242,885 - $434,121	-26,487 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$9.15 - $11.09 $43,837 - $53,132	4,791 Added 22.08%	26,487 $346,000
Q2 2021 Aug 09, 2021	BUY	$10.24 - $20.87 $222,167 - $452,795	21,696 New	21,696 $222,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.